| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income | ||||||
1,937 | 1,581 | -16 | ||||
Adjustments to reconcile net income to cash used in operating activities: | ||||||
Interest income | ||||||
3,854 | 2,687 | 0 | ||||
Unrealized gains (losses) on marketable securities | ||||||
95 | -17 | 0 | ||||
Deferred tax expense | ||||||
16 | - | - | ||||
Changes in operating assets and liabilities: | ||||||
Changes in prepaid expenses and other current assets | ||||||
-81 | 102 | 12 | ||||
Changes in accounts payable and accrued expenses | ||||||
230 | 153 | 1 | ||||
Changes in income taxes receivable | ||||||
- | - | 0 | ||||
Changes in income taxes receivable | ||||||
35 | -30 | - | ||||
Net cash used by operating activities | ||||||
-1,649 | -1,066 | -27 | ||||
Cash flows from investing activities: | ||||||
Investment of cash in Trust Account | ||||||
- | 174,225 | 0 | ||||
Interest income released from Trust Account for payment of taxes | ||||||
-902 | -450 | - | ||||
The cash outflow associated with interest income released from trust account for taxes during the period. | ||||||
- | - | 0 | ||||
Net cash provided by (used in) investing activities | ||||||
902 | -173,774 | 0 | ||||
Cash flows from financing activities: | ||||||
Proceeds from sale of Units in Public Offering | ||||||
- | 169,500 | 0 | ||||
Proceeds from Sponsor Loan | ||||||
500 | 1,725 | - | ||||
Proceeds from Sponsor Loan | ||||||
- | - | 0 | ||||
Proceeds from sale of Private Placement Warrants | ||||||
- | 4,500 | 0 | ||||
Note payable borrowings | ||||||
- | 45 | 12 | ||||
Repayment of Note payable borrowings | ||||||
- | -250 | 0 | ||||
Advance from Sponsor | ||||||
- | 74 | 0 | ||||
Repayment of Advance from Sponsor | ||||||
- | 69 | 0 | ||||
Payment of offering costs | ||||||
- | 364 | 5 | ||||
Net cash provided by financing activities | ||||||
500 | 171,161 | 7 | ||||
Increase (decrease) in cash | ||||||
-246 | 319 | -19 | ||||
Cash paid for taxes | ||||||
607 | 450 | 0 | ||||
Supplemental disclosure of non-cash investing and financing activities: | ||||||
The amount of deferred offering costs included in accrued offering costs. | ||||||
- | - | 28 | ||||
Deferred underwriting commissions | ||||||
- | 7,350 | 0 | ||||
Payment of deferred offering cost directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. | ||||||
- | - | 25 | ||||
Initial value of common shares subject to possible redemption | ||||||
- | 161,033 | 0 | ||||